Zoetis: Unleashing Margin Expansion; Initiate Strong Buy

We initiate coverage on Zoetis with a Strong Buy rating and a $219.26 price target, driven by explosive growth in companion animal products and structural margin expansion. Zoetis's leadership in companion animal therapeutics, particularly with Librela and Simparica, supports our above-consensus EPS forecasts of $6.12 for FY25 and $6.80 for FY26. The divestiture of lower-margin feed additives enables strategic R&D reinvestment, bolstering innovation and operational growth, while maintaining competitive moats in key markets....

Seeking Alpha - 5/4/2025 8:53:53 AM More News for ZTS
Stock Analysis for ZTS
Related Stocks: